Related Experiment Video
Updated: Mar 3, 2026
08:41
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
1.9K
Metabolic liver imaging: What you need to know.
Luigi Asmundo1, Amirkasra Mojtahed2, Samay Prakash3
1Department of Radiology, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.
Summary
Imaging techniques offer non-invasive ways to diagnose and manage metabolic liver diseases. This review covers current methods like MRI and CT, focusing on quantitative biomarkers and future AI applications for better patient care.
Area of Science:
- Hepatology
- Radiology
- Medical Imaging
Background:
- Metabolic liver diseases are a growing global health issue.
- Accurate diagnosis and prognosis are crucial for patient management.
- Traditional biopsy has limitations; non-invasive imaging is needed.
Purpose of the Study:
- To review current imaging techniques for metabolic liver disease.
- To highlight quantitative biomarkers and their clinical utility.
- To propose a framework for imaging-based assessment.
Main Methods:
- Review of current literature on imaging modalities.
- Inclusion of ultrasound (US), CT, MRI, MRI elastography, and PET/MRI.
- Focus on quantitative biomarkers: elastography, PDFF, R2* mapping.
Main Results:
- Various imaging techniques (US, CT, MRI) are used for metabolic liver disease.
- Advanced MRI techniques and quantitative biomarkers offer improved assessment.
- Artificial intelligence and radiomics show future potential.
Conclusions:
- Imaging provides essential non-invasive tools for metabolic liver disease diagnosis and management.
- Quantitative biomarkers and advanced imaging enhance diagnostic accuracy.
- An integrated imaging-based framework can optimize patient care.
